Antino Allen
Concepts (224)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hippocampus | 24 | 2023 | 228 | 9.060 |
Why?
| Cognition | 13 | 2023 | 338 | 4.020 |
Why?
| Behavior, Animal | 9 | 2021 | 181 | 3.520 |
Why?
| Cosmic Radiation | 9 | 2021 | 31 | 2.810 |
Why?
| Dendrites | 6 | 2020 | 29 | 2.570 |
Why?
| Dendritic Spines | 10 | 2020 | 21 | 2.370 |
Why?
| Cyclophosphamide | 4 | 2021 | 165 | 2.210 |
Why?
| Oxygen | 4 | 2021 | 326 | 2.190 |
Why?
| Mice, Inbred C57BL | 32 | 2022 | 1816 | 2.060 |
Why?
| Neurons | 5 | 2021 | 460 | 1.750 |
Why?
| Mice | 34 | 2023 | 5739 | 1.710 |
Why?
| Animals | 43 | 2023 | 13187 | 1.530 |
Why?
| Doxorubicin | 3 | 2021 | 233 | 1.430 |
Why?
| Maze Learning | 7 | 2021 | 35 | 1.400 |
Why?
| Fluorouracil | 3 | 2020 | 54 | 1.400 |
Why?
| Social Behavior | 2 | 2020 | 72 | 1.350 |
Why?
| Methotrexate | 2 | 2020 | 69 | 1.260 |
Why?
| Hydrogen | 2 | 2018 | 13 | 1.230 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2022 | 989 | 1.230 |
Why?
| Minority Groups | 2 | 2024 | 132 | 1.040 |
Why?
| Biomedical Research | 3 | 2024 | 237 | 0.960 |
Why?
| Memory | 4 | 2020 | 116 | 0.940 |
Why?
| Isothiocyanates | 1 | 2023 | 17 | 0.910 |
Why?
| Students | 3 | 2024 | 210 | 0.900 |
Why?
| Fertility Preservation | 1 | 2023 | 8 | 0.880 |
Why?
| Space Flight | 3 | 2021 | 34 | 0.870 |
Why?
| Sirtuin 3 | 1 | 2023 | 19 | 0.870 |
Why?
| Brain | 6 | 2021 | 1328 | 0.840 |
Why?
| Cranial Irradiation | 2 | 2020 | 21 | 0.840 |
Why?
| Poverty | 1 | 2024 | 201 | 0.830 |
Why?
| Dentate Gyrus | 8 | 2020 | 17 | 0.830 |
Why?
| Dioxolanes | 1 | 2022 | 12 | 0.810 |
Why?
| Neuroprotective Agents | 1 | 2022 | 105 | 0.750 |
Why?
| Metalloporphyrins | 1 | 2020 | 7 | 0.720 |
Why?
| Male | 30 | 2024 | 25243 | 0.690 |
Why?
| Paclitaxel | 1 | 2020 | 84 | 0.690 |
Why?
| Neuronal Plasticity | 2 | 2017 | 58 | 0.690 |
Why?
| Rural Population | 1 | 2024 | 540 | 0.680 |
Why?
| Solar Activity | 2 | 2021 | 7 | 0.670 |
Why?
| Thiotepa | 1 | 2019 | 5 | 0.670 |
Why?
| CA1 Region, Hippocampal | 5 | 2020 | 24 | 0.660 |
Why?
| Oxidation-Reduction | 1 | 2020 | 322 | 0.650 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2019 | 74 | 0.650 |
Why?
| Dose-Response Relationship, Radiation | 10 | 2019 | 184 | 0.640 |
Why?
| Radiation Injuries | 3 | 2015 | 113 | 0.640 |
Why?
| Oxygen Radioisotopes | 1 | 2018 | 14 | 0.620 |
Why?
| Memory, Short-Term | 2 | 2019 | 73 | 0.610 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2017 | 37 | 0.610 |
Why?
| Cytarabine | 1 | 2017 | 39 | 0.600 |
Why?
| Eflornithine | 2 | 2014 | 7 | 0.600 |
Why?
| Oxidative Stress | 6 | 2023 | 770 | 0.590 |
Why?
| Tissue Fixation | 1 | 2017 | 36 | 0.590 |
Why?
| Antioxidants | 5 | 2023 | 249 | 0.580 |
Why?
| Staining and Labeling | 1 | 2017 | 97 | 0.570 |
Why?
| Cognition Disorders | 3 | 2015 | 218 | 0.560 |
Why?
| Receptors, CCR2 | 2 | 2013 | 14 | 0.560 |
Why?
| Neoplasms | 2 | 2023 | 1235 | 0.510 |
Why?
| Brain Injuries | 2 | 2014 | 160 | 0.500 |
Why?
| Radiation Injuries, Experimental | 2 | 2014 | 81 | 0.490 |
Why?
| Immunosuppressive Agents | 1 | 2016 | 221 | 0.490 |
Why?
| Antineoplastic Agents | 1 | 2023 | 1171 | 0.490 |
Why?
| Up-Regulation | 1 | 2016 | 452 | 0.490 |
Why?
| Whole-Body Irradiation | 5 | 2017 | 131 | 0.490 |
Why?
| Learning | 1 | 2015 | 158 | 0.460 |
Why?
| Female | 12 | 2024 | 26474 | 0.460 |
Why?
| Electric Fish | 1 | 2012 | 1 | 0.430 |
Why?
| Nerve Regeneration | 1 | 2012 | 21 | 0.430 |
Why?
| Iron | 6 | 2015 | 122 | 0.430 |
Why?
| Central Nervous System | 1 | 2013 | 85 | 0.420 |
Why?
| Aging | 2 | 2019 | 687 | 0.420 |
Why?
| Career Choice | 2 | 2024 | 111 | 0.420 |
Why?
| Spinal Cord Injuries | 1 | 2012 | 55 | 0.410 |
Why?
| Neurogenesis | 3 | 2020 | 27 | 0.390 |
Why?
| Disease Models, Animal | 3 | 2023 | 1455 | 0.380 |
Why?
| Time Factors | 5 | 2019 | 2903 | 0.370 |
Why?
| Age Factors | 1 | 2014 | 1087 | 0.370 |
Why?
| Mitochondria | 3 | 2023 | 402 | 0.350 |
Why?
| Hematopoietic Stem Cells | 3 | 2017 | 184 | 0.340 |
Why?
| Receptors, AMPA | 2 | 2019 | 17 | 0.320 |
Why?
| Cell Proliferation | 1 | 2012 | 1007 | 0.320 |
Why?
| Heavy Ions | 4 | 2015 | 15 | 0.320 |
Why?
| Radiation, Ionizing | 3 | 2019 | 100 | 0.310 |
Why?
| Synapses | 2 | 2019 | 87 | 0.300 |
Why?
| Gene Expression Regulation | 3 | 2018 | 976 | 0.290 |
Why?
| Receptors, N-Methyl-D-Aspartate | 2 | 2019 | 127 | 0.290 |
Why?
| Exploratory Behavior | 2 | 2018 | 23 | 0.290 |
Why?
| Proteomics | 2 | 2020 | 329 | 0.290 |
Why?
| RNA, Messenger | 2 | 2022 | 1105 | 0.290 |
Why?
| Electromagnetic Radiation | 3 | 2016 | 4 | 0.270 |
Why?
| Quality of Life | 2 | 2022 | 836 | 0.250 |
Why?
| Signal Transduction | 3 | 2022 | 1618 | 0.250 |
Why?
| Cytokines | 2 | 2019 | 612 | 0.240 |
Why?
| Inflammation | 2 | 2022 | 604 | 0.240 |
Why?
| Cultural Diversity | 1 | 2024 | 38 | 0.230 |
Why?
| Sulfoxides | 1 | 2023 | 19 | 0.230 |
Why?
| Leadership | 1 | 2024 | 101 | 0.220 |
Why?
| Animals, Wild | 1 | 2023 | 8 | 0.220 |
Why?
| Self Efficacy | 1 | 2024 | 129 | 0.220 |
Why?
| Histone Deacetylases | 1 | 2023 | 50 | 0.220 |
Why?
| Lung | 3 | 2016 | 486 | 0.210 |
Why?
| Extraterrestrial Environment | 2 | 2021 | 7 | 0.210 |
Why?
| Ovary | 1 | 2023 | 104 | 0.210 |
Why?
| Reproduction | 1 | 2023 | 61 | 0.210 |
Why?
| Superoxide Dismutase | 1 | 2023 | 113 | 0.210 |
Why?
| Breast Neoplasms | 2 | 2022 | 1174 | 0.200 |
Why?
| Cell Separation | 1 | 2021 | 89 | 0.190 |
Why?
| Education, Graduate | 1 | 2021 | 14 | 0.190 |
Why?
| Glucose Transporter Type 1 | 1 | 2020 | 17 | 0.190 |
Why?
| Epigenesis, Genetic | 2 | 2014 | 374 | 0.190 |
Why?
| rac1 GTP-Binding Protein | 1 | 2020 | 11 | 0.190 |
Why?
| School Admission Criteria | 1 | 2021 | 37 | 0.180 |
Why?
| Sirtuins | 1 | 2020 | 11 | 0.180 |
Why?
| Cardiovascular System | 1 | 2021 | 49 | 0.180 |
Why?
| Radiation Dosage | 3 | 2015 | 157 | 0.180 |
Why?
| Amyloid beta-Peptides | 1 | 2020 | 69 | 0.180 |
Why?
| Silver Staining | 2 | 2016 | 9 | 0.180 |
Why?
| Chemotherapy, Adjuvant | 1 | 2020 | 119 | 0.170 |
Why?
| Radiation-Protective Agents | 1 | 2020 | 74 | 0.170 |
Why?
| Injections, Intraperitoneal | 1 | 2019 | 54 | 0.170 |
Why?
| Reactive Oxygen Species | 3 | 2017 | 408 | 0.160 |
Why?
| Astrocytes | 1 | 2020 | 145 | 0.160 |
Why?
| Flow Cytometry | 1 | 2021 | 476 | 0.160 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2019 | 22 | 0.160 |
Why?
| Osteogenesis | 1 | 2021 | 352 | 0.160 |
Why?
| Protein Subunits | 1 | 2019 | 77 | 0.160 |
Why?
| Relative Biological Effectiveness | 1 | 2018 | 8 | 0.160 |
Why?
| Movement | 1 | 2019 | 82 | 0.160 |
Why?
| Proton Therapy | 1 | 2018 | 10 | 0.160 |
Why?
| Osteoclasts | 1 | 2021 | 425 | 0.160 |
Why?
| Leukocyte Count | 1 | 2018 | 70 | 0.160 |
Why?
| Injections, Spinal | 1 | 2017 | 19 | 0.150 |
Why?
| Bromodeoxyuridine | 2 | 2014 | 19 | 0.150 |
Why?
| Blood Glucose | 1 | 2020 | 438 | 0.150 |
Why?
| Leukocytes | 1 | 2017 | 66 | 0.150 |
Why?
| CA3 Region, Hippocampal | 1 | 2017 | 5 | 0.150 |
Why?
| Models, Animal | 1 | 2018 | 233 | 0.150 |
Why?
| Young Adult | 2 | 2024 | 3958 | 0.150 |
Why?
| DNA Methylation | 3 | 2016 | 548 | 0.140 |
Why?
| Stress, Psychological | 1 | 2019 | 260 | 0.140 |
Why?
| Alzheimer Disease | 1 | 2020 | 324 | 0.140 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 92 | 0.140 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2016 | 38 | 0.140 |
Why?
| Radio Waves | 1 | 2016 | 8 | 0.140 |
Why?
| Cytoskeletal Proteins | 2 | 2013 | 49 | 0.130 |
Why?
| Pattern Recognition, Visual | 1 | 2015 | 20 | 0.130 |
Why?
| Humans | 8 | 2024 | 49978 | 0.130 |
Why?
| Microglia | 2 | 2014 | 141 | 0.130 |
Why?
| Bone Marrow | 1 | 2017 | 362 | 0.120 |
Why?
| Catalase | 1 | 2015 | 67 | 0.120 |
Why?
| Nerve Tissue Proteins | 2 | 2013 | 193 | 0.120 |
Why?
| Thioredoxins | 1 | 2014 | 24 | 0.120 |
Why?
| Silicon | 1 | 2014 | 8 | 0.120 |
Why?
| Radioisotopes | 1 | 2014 | 16 | 0.120 |
Why?
| Apoptosis | 2 | 2017 | 1101 | 0.120 |
Why?
| Gene Expression Profiling | 1 | 2018 | 1032 | 0.110 |
Why?
| Immunohistochemistry | 2 | 2014 | 973 | 0.110 |
Why?
| Cell Count | 1 | 2012 | 147 | 0.100 |
Why?
| Fear | 1 | 2013 | 82 | 0.100 |
Why?
| Cell Differentiation | 1 | 2015 | 651 | 0.100 |
Why?
| Adult | 2 | 2024 | 13236 | 0.090 |
Why?
| Cell Survival | 1 | 2012 | 600 | 0.090 |
Why?
| Protons | 3 | 2015 | 69 | 0.090 |
Why?
| Mice, Transgenic | 2 | 2020 | 555 | 0.070 |
Why?
| Gymnotiformes | 1 | 2004 | 1 | 0.060 |
Why?
| Nitrergic Neurons | 1 | 2004 | 1 | 0.060 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 2015 | 96 | 0.060 |
Why?
| Citrulline | 1 | 2004 | 95 | 0.060 |
Why?
| DNA Damage | 2 | 2017 | 301 | 0.060 |
Why?
| Health Occupations | 1 | 2022 | 20 | 0.050 |
Why?
| Nitric Oxide | 1 | 2004 | 253 | 0.050 |
Why?
| Mentors | 1 | 2022 | 55 | 0.050 |
Why?
| Cells, Cultured | 2 | 2017 | 1573 | 0.050 |
Why?
| Analysis of Variance | 2 | 2013 | 562 | 0.050 |
Why?
| Neuropsychological Tests | 2 | 2013 | 353 | 0.050 |
Why?
| Astronauts | 1 | 2021 | 5 | 0.050 |
Why?
| Mice, Inbred BALB C | 1 | 2021 | 304 | 0.050 |
Why?
| Program Evaluation | 1 | 2022 | 354 | 0.050 |
Why?
| Radiation Protection | 1 | 2021 | 47 | 0.050 |
Why?
| Universities | 1 | 2021 | 161 | 0.040 |
Why?
| Risk | 1 | 2020 | 320 | 0.040 |
Why?
| Peptide Fragments | 1 | 2020 | 215 | 0.040 |
Why?
| Tissue Extracts | 1 | 2019 | 13 | 0.040 |
Why?
| Educational Measurement | 1 | 2021 | 208 | 0.040 |
Why?
| Inflammation Mediators | 1 | 2019 | 112 | 0.040 |
Why?
| Insulin | 1 | 2020 | 457 | 0.040 |
Why?
| Gene Expression | 1 | 2020 | 609 | 0.040 |
Why?
| Injections, Intravenous | 1 | 2018 | 140 | 0.040 |
Why?
| Ovariectomy | 1 | 2018 | 119 | 0.040 |
Why?
| Drug Synergism | 1 | 2018 | 150 | 0.040 |
Why?
| DNA Repair | 1 | 2018 | 193 | 0.040 |
Why?
| Motor Activity | 1 | 2018 | 229 | 0.030 |
Why?
| Azacitidine | 1 | 2016 | 34 | 0.030 |
Why?
| Ferrous Compounds | 1 | 2016 | 8 | 0.030 |
Why?
| Cell Cycle | 1 | 2017 | 231 | 0.030 |
Why?
| Interleukin-13 | 1 | 2015 | 15 | 0.030 |
Why?
| Linear Energy Transfer | 1 | 2015 | 14 | 0.030 |
Why?
| Synaptosomes | 1 | 2015 | 15 | 0.030 |
Why?
| Arkansas | 1 | 2021 | 1978 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 476 | 0.030 |
Why?
| Gene Dosage | 1 | 2014 | 78 | 0.030 |
Why?
| Pulmonary Fibrosis | 1 | 2014 | 18 | 0.030 |
Why?
| Long-Term Potentiation | 1 | 2014 | 31 | 0.030 |
Why?
| Histones | 1 | 2016 | 312 | 0.030 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2014 | 38 | 0.030 |
Why?
| Lung Injury | 1 | 2014 | 25 | 0.030 |
Why?
| Iron Radioisotopes | 1 | 2013 | 2 | 0.030 |
Why?
| Phosphopyruvate Hydratase | 1 | 2013 | 9 | 0.030 |
Why?
| Electroshock | 1 | 2013 | 10 | 0.030 |
Why?
| Freezing Reaction, Cataleptic | 1 | 2013 | 5 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2015 | 688 | 0.030 |
Why?
| Spatial Behavior | 1 | 2012 | 10 | 0.030 |
Why?
| Polyamines | 1 | 2012 | 9 | 0.030 |
Why?
| Swimming | 1 | 2012 | 22 | 0.030 |
Why?
| Obesity | 1 | 2020 | 1113 | 0.030 |
Why?
| Golgi Apparatus | 1 | 2012 | 99 | 0.020 |
Why?
| Mice, Knockout | 1 | 2013 | 841 | 0.020 |
Why?
| Enzyme Inhibitors | 1 | 2012 | 391 | 0.020 |
Why?
| Lung Neoplasms | 1 | 2014 | 606 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2013 | 2182 | 0.020 |
Why?
| Electric Organ | 1 | 2004 | 2 | 0.020 |
Why?
| Avoidance Learning | 1 | 2004 | 17 | 0.020 |
Why?
| Nitric Oxide Synthase | 1 | 2004 | 75 | 0.020 |
Why?
| Tissue Distribution | 1 | 2004 | 163 | 0.010 |
Why?
| Perception | 1 | 2004 | 116 | 0.010 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|